COMMUNIQUÉS West-GlobeNewswire

Takeda et TiGenix annoncent les résultats de la deuxième période d'acceptation pour l'offre publique d'acquisition volontaire et conditionnelle de TiGenix

06/07/2018 - 07:01

COMMUNIQUÉ DE PRESSE Takeda et TiGenix annoncent les résultats de la deuxième période d'acceptation pour l'offre publique d'acquisition volontaire et conditionnelle de TiGenix, le début du retrait simplifié et son [...]

Eisai and Biogen Announce Positive Topline Results of the Final Analysis for BAN2401 at 18 Months

06/07/2018 - 01:30

The final analysis at 18 months of the 856 patient Phase II clinical study in early Alzheimer’s disease demonstrated statistically significant slowing in clinical decline and reduction of amyloid beta accumulated in the [...]

LADAVRU® NEWS “HOVERINK BIOTECHNOLOGIES SEEKS COMMERCIAL PARTNERING OPPORTUNITIES IN ONCOLOGY SUPPORTIVE THERAPIES AND SEEKS A COMMERCIALIZATION AGREEMENT FOR ITS INVESTIGATIONAL DRUG LADAVRU®”

06/07/2018 - 01:20

LOS ANGELES, CA, July 05, 2018 (GLOBE NEWSWIRE) -- HOVERINK BIOTECHNOLOGIES , seeks to enter into a licensing agreement for the exclusive rights to commercialize LADAVRU(TM) (Dronabinol for injection) and an oral [...]

Fibrocell Announces Closing of $4.0 Million Registered Direct Offering

05/07/2018 - 22:05

EXTON, Pa., July 05, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ:FCSC), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, today [...]

Fluidigm Announces Conference Call and Webcast of Second Quarter 2018 Financial Results

05/07/2018 - 22:05

SOUTH SAN FRANCISCO, Calif., July 05, 2018 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative life science company that develops, manufactures and markets multiparameter mass cytometry and proprietary [...]

Intuitive Surgical Receives FDA Clearance for First 60mm Stapler

05/07/2018 - 21:36

A new breed of da Vinci ® stapling compatible with the da Vinci Xi and X surgical systems SUNNYVALE, Calif., July 05, 2018 (GLOBE NEWSWIRE) -- Intuitive Surgical, Inc. (Nasdaq:ISRG), the pioneer and a global technology [...]

Tom Ripp Joins Analogic as President, Security and Detection

05/07/2018 - 20:30

PEABODY, Mass., July 05, 2018 (GLOBE NEWSWIRE) -- Analogic Corporation, a leading provider of advanced imaging technologies to the medical imaging and security industries, today announced and welcomed the addition of Mr [...]

Molina Healthcare Announces Second Quarter 2018 Earnings Release and Conference Call Dates

05/07/2018 - 20:00

LONG BEACH, Calif., July 05, 2018 (GLOBE NEWSWIRE) -- Molina Healthcare, Inc. (NYSE: MOH) today announced details for the release of its results for the second quarter ended June 30, 2018. Molina Healthcare will issue [...]

NeuroMetrix Announces Issuance of New U.S. Patent for DPNCheck Point-of-Care Neuropathy Test Technology

05/07/2018 - 19:00

WALTHAM, Mass., July 05, 2018 (GLOBE NEWSWIRE) -- NeuroMetrix, Inc. (Nasdaq:NURO) announced today that the U.S. Patent and Trademark Office has issued U.S. Patent No. 10,004,445. The patent covers novel technology that [...]

OSE Immunotherapeutics Receives a €435,000 Translational Research Grant to Develop Precision Medicine Targeting for Tedopi®

05/07/2018 - 18:00

Funding through the Eurostars European Programme, led in France by Bpifrance NANTES, France, July 05, 2018 (GLOBE NEWSWIRE) -- OSE Immunotherapeutics SA (ISIN:FR0012127173) (Mnémo:OSE) today announces that the Company [...]

GENFIT: HALF-YEAR REPORT OF LIQUIDITY CONTRACT WITH CIC

05/07/2018 - 17:46

GENFIT: HALF-YEAR REPORT OF LIQUIDITY CONTRACT WITH CIC Lille (France), Cambridge (Massachusetts, United States), July 5, 2018 - GENFIT (Euronext: GNFT - ISIN: FR0004163111), is a biopharmaceutical company focused on [...]

GENFIT : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE CONTRACTE AVEC CIC

05/07/2018 - 17:46

GENFIT : BILAN SEMESTRIEL DU CONTRAT DE LIQUIDITE CONTRACTE AVEC CIC Lille (France), Cambridge (Massachusetts, Etats-Unis), le 5 juillet 2018 - GENFIT (Euronext : GNFT - ISIN : FR0004163111), société biopharmaceutique [...]

Lexaria DehydraTECH Shows Promise in Nervous System Disorders -- CFN Media

05/07/2018 - 15:00

SEATTLE, WA, July 05, 2018 (GLOBE NEWSWIRE) -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, today announced publication of an article [...]

FIT Biotech Oy: Conversion of FIT Biotech Oy's Convertible Capital Notes into shares

05/07/2018 - 14:31

FIT Biotech Oy Company release July 5, 2018 at 03:30 PM EET Conversion of FIT Biotech Oy's Convertible Capital Notes into shares Related to Convertible Note and Warrant Programmes established on December 22, 2017 [...]

Hemostemix Formalizes World-Class Scientific Advisory Board

05/07/2018 - 14:30

CALGARY, Alberta, July 05, 2018 (GLOBE NEWSWIRE) -- Hemostemix Inc. (“ Hemostemix ” or the “ Company ”) (TSX-V:HEM) is pleased to announce the formalization of its Scientific Advisory Board (“SAB”). Members of the SAB [...]

Top Solar System Engineer Joins International Endeavors Corp.

05/07/2018 - 14:30

TEMECULA, Calif., July 05, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- International Endeavors Corporation (OTC: IDVV) announces today it has secured renewable energy expert Jason Andrade as a consultant for the company [...]

IntelGenx Receives CIPO Notice of Allowance for Loxapine VersaFilm™ Patent

05/07/2018 - 14:00

SAINT LAURENT, Quebec, July 05, 2018 (GLOBE NEWSWIRE) -- IntelGenx Corp. (TSXV:IGX) (OTCQX:IGXT) (“IntelGenx” or the “Company”), a leading oral drug delivery company primarily focused on the development and [...]

Pivotal Trial Data for SIGA Technologies’ Oral TPOXX® Published in the New England Journal of Medicine

05/07/2018 - 13:30

- Results support the use of TPOXX to treat smallpox, a highly contagious and lethal virus that poses significant bioterror threat - NEW YORK, July 05, 2018 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: [...]

Zynerba Pharmaceuticals Announces Top Line Results from ZYN001 THC-Prodrug Patch Phase 1 Study

05/07/2018 - 13:30

DEVON, Pa., July 05, 2018 (GLOBE NEWSWIRE) -- Zynerba Pharmaceuticals , Inc. (NASDAQ:ZYNE), the leader in innovative pharmaceutically-produced transdermal cannabinoid therapies for rare and near-rare neuropsychiatric [...]